Revuforj

NDC 73555-502 · Syndax Pharmaceuticals, Inc.

Generic namerevumenib

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)REVUMENIB CITRATE

Strength160 mg/1

Pharmacologic classMenin Inhibitor [EPC], Menin Inhibitors [MoA]

Marketing categoryNDA

Packages

73555-502-00 — 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (73555-502-00)

FDA lists these products with the same active ingredient.

73555-500 — revumenib, 73555-501 — revumenib

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.